Mark S. Levine
CIK 1617236 · View on SEC EDGAR ↗
First SEC filing: March 5, 2026 · Latest: March 5, 2026
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 1, 2017 | NERV | S 10b5-1 | 17,500 | $11.00 | $192,500 | 0 Direct | -100.00% | Disposed | -94.4% (price as of 2026-08-19) |
| Jan. 4, 2017 | NERV | S 10b5-1 | 17,500 | $12.00 | $210,000 | 0 Direct | -100.00% | Disposed | -94.8% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 1, 2017 | NERV | Employee Stock Option (Right to Buy) | Common Stock (17,500) | $5.19 | April 13, 2025 | 17,500 | Disposed |
| Jan. 4, 2017 | NERV | Stock Option (Right to Buy) | Common Stock (250) | $5.19 | April 13, 2025 | 250 | Disposed |
| Jan. 4, 2017 | NERV | Stock Option (Right to Buy) | Common Stock (17,250) | $4.71 | Dec. 3, 2025 | 17,250 | Disposed |
| Dec. 14, 2016 | NERV | Restricted Stock Units | Common Stock (20,000) | — | — | 20,000 | Acquired |
| Dec. 14, 2016 | NERV | Employee Stock Option (Right to Buy) | Common Stock (35,000) | — | Dec. 13, 2026 | 35,000 | Acquired |
| Dec. 4, 2015 | NERV | Stock Option (right to buy) | Common Stock (69,000) | — | Dec. 3, 2025 | 69,000 | Acquired |
| April 14, 2015 | NERV | Stock Option (right to buy) | Common Stock (57,524) | — | April 13, 2025 | 57,524 | Acquired |
| Sept. 2, 2014 | NERV | Employee Stock Option (Right to Buy) | Common Stock (93,541) | $7.10 | Sept. 2, 2024 | 93,541 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
MASS
Chief Legal and Administrative Officer and Secretary| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | — | — | — | — | — | — | — | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.